Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

Conditions: Pain, Sleep, Anxiety, Depression, Epilepsy

Sex: All

Ages: 19 Years – N/A

Enrollment: 1000

Sponsor: University Health Network, Toronto

Location: Toronto General Hospital, UHN Toronto Ontario

Summary

This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.

Eligibility Criteria

Inclusion Criteria: * Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent * Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression. * Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study Exclusion Criteria: * Concomitant use of illicit drugs * Concomitant use of recreational cannabis

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04526093). StuddyBuddy aggregates publicly available trial information.